Kenalog

(Triamcinolone)

ApprovedSmall molecule

Triamcinolone is a steroid medication used to reduce inflammation and suppress the immune system, helping treat conditions like allergies, asthma, skin conditions, and joint inflammation.[2] Kenalog is currently approved and in use across 53 indications[4].[1]

Kenalog is one of 584 small molecule programs targeting Lumbar Disc Herniation. It is currently in Approved.

Indications

Total Trials

Active Trials

583

Competitors

FDA Applications

NDA/BLA/ANDA regulatory filings

Pipeline

Status by Indication[4][1]

Indication

Lumbar Disc HerniationActive, not recruiting

DysphagiaActive, not recruiting

Carpal Tunnel SyndromeActive, not recruiting

Anterior Ischemic Optic NeuropathyApproved

Shoulder Impingement SyndromeActive, not recruiting

Atopic EczemaApproved

SinusitisApproved

HemorrhoidActive, not recruiting

RadiculopathyApproved

Wet Macular DegenerationApproved

Lumbar Disc HerniationPreclinical

Active, not recruiting

DysphagiaPreclinical

Active, not recruiting

Carpal Tunnel SyndromePreclinical

Active, not recruiting

Anterior Ischemic Optic NeuropathyApproved

Approved

Shoulder Impingement SyndromePreclinical

Active, not recruiting

Atopic EczemaApproved

Approved

SinusitisApproved

Approved

HemorrhoidApproved

Active, not recruiting

RadiculopathyApproved

Approved

Wet Macular DegenerationApproved

Approved

Showing 10 of 53 indications

Competition

Competitive Landscape

141 competitors in Osteoarthritis

#DrugCompanyPhaseTrials

Kenalog

BBassett Healthcare

Approved

4 2

Toradol

Roche

Preclinical

1 3

Cataflam

Bayer Aspirin

Enbrel

2 6

MS Contin

HHikma Pharmaceuticals LLC

Preclinical

1 7

Catapres

Boehringer Ingelheim

Preclinical

1 8

Glucophage

EMD Serono

Preclinical

1 9

Lunesta

Akero Therapeutics

Preclinical

1 10

Chirocaine

PPurdue Pharma LP

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q4 2026

Phase 1Recruiting

Psoriasis

NCT04036188

Phase 3Recruiting

Arthritis

NCT05992883

Q1 2027

PreclinicalRecruiting

Peripheral Nerve Stimulation

NCT06004882

Q3 2027

Phase 1Active, not recruiting

Analgesia

NCT04126824

Q4 2027

Phase 3Recruiting

Hip Osteoarthritis

NCT04990128

Clinical

Trials by Indication[1]

Steroid4 trials

Addition of a Topical Steroid to a Topical Retinoid in Acne Patients

Unknown status·CCarilion Clinic·N/A·NCT02704507·20 enrolled

Evaluation of the Effect of Adding Corticosteroid to Viscosupplementation

Completed·UUniversity of Sao Paulo General Hospital·Phase 4·NCT01335321·108 enrolled

Steroid-reducing Effects of Crisaborole

Completed·JJohns Hopkins University·Phase 4·NCT03832010·24 enrolled

Show 1 more trial

A Study of Topical Steroids as Preemptive Therapy for EGFR Inhibitor-Induced Papulopustular Eruption

Terminated·NNorthwestern University·Phase 2·NCT03115567·14 enrolled

Osteoarthritis4 trials

Gait Patterns After Intraarticular Treatment of Patients With Osteoarthritis of the Knee

Completed·PPhilipps University Marburg·Phase 4·NCT00731289·60 enrolled

Corticosteroid vs Platelet-Rich Plasma Intra-articular Injections in the Treatment of Knee Osteoarthritis.

Unknown status·TThe University of The West Indies·Phase 1·NCT06032039·160 enrolled

Osteoarthritis Shoulder Injection Study

Terminated·MMilton S. Hershey Medical Center·Phase 4·NCT03586687·19 enrolled

Show 1 more trial

Additional Effects of Triamcinolone to Hyaluronic Acid on Knee Osteoarthritis

Unknown status·TTaipei Medical University·Phase 4·NCT02949466·56 enrolled

Diabetic Macular Edema4 trials

Intraocular Anti-VEGF Compared With Intraocular Triamcinolone in Patients With Diabetic Macular Edema

Completed·MMedical University of Vienna·Phase 4·NCT00682539·71 enrolled

Efficacy Study of Triamcinolone and Bevacizumab Intravitreal for Treatment of Diabetic Macular Edema

Completed·RRubens Belfort Jr.·Phase 4·NCT00737971·142 enrolled

The Effect of Intravitral Injection of Triamcinolone Combined With Cataract Surgery (Phacoemulsification) on Diabetic Macular Edema and Diabetic Retinopathy

Unknown status·SShahid Beheshti University of Medical Sciences·Phase 1/2·NCT00849537

Show 1 more trial

A Pilot Study of Peribulbar Triamcinolone Acetonide for Diabetic Macular Edema

Completed·JJaeb Center for Health Research·Phase 2·NCT00369486·113 enrolled

Keloid4 trials

Pressure Device in the Treatment of Ear Keloids

Completed·UUniversity of Ulm·N/A·NCT02962518·18 enrolled

Treatment of Keloidscars With Intralesional Triamcinolone and 5-fluorouracil Injections-prospective, Randomized, Controlled Trial - Pilot Study

Completed·TTampere University Hospital·Phase 4·NCT02155439·50 enrolled

Keloid Scarring: Treatment and Pathophysiology

Withdrawn·QQueen Mary University of London·Phase 4·NCT01295099

Show 1 more trial

Post-Surgical Injection With Triamcinolone Versus Triamcinolone/Fluorouracil in Treatment of Keloids

Completed·OOur Lady of the Lake Hospital·N/A·NCT04710719·7 enrolled

Steroid Injection4 trials

Percutaneous Trigger Finger Release Concomitant Steroid Injection Versus Percutaneous Trigger Finger Release Alone

Completed·—·Phase 3·NCT06288685·38 enrolled

Is the Efficacy of Epidural Steroid Injections Related to the Different Volume Injections?

Completed·NNeslihan Uztüre·N/A·NCT02343432·75 enrolled

Evaluation of the Role of Local Steroid Injection in Treatment of Idiopathic Spasmodic Flat Foot in Adolescent Patients

Unknown status·—·N/A·NCT05381558·20 enrolled

Show 1 more trial

C7-T1 Epidural Steroid Injections Versus Targeted Injection for Treatment of Cervical Radicular Pain

Completed·NNorthwestern University·Phase 4·NCT02095197·79 enrolled

52 more indications

Arthritis3 trials

NSAID Injection Versus Corticosteroid Injection for Basilar Thumb Arthritis

Recruiting·MMayo Clinic·Phase 3·NCT05992883·240 enrolled

Psoriatic Oligoarthritis Intervention With Symptomatic thErapy

Completed·UUniversity of Oxford·Phase 4·NCT03797872·1 enrolled

NEUROIMPA - Intraarticular Application of Opioids in Chronic Arthritis of the Knee Joint

Unknown status·HHildrun Haibel·Phase 2/3·NCT02967302·112 enrolled

Atopic Dermatitis3 trials

Utilization of a Microdevice for Psoriasis and Atopic Dermatitis

Not yet recruiting·UUniversity of California, San Francisco·Phase 4·NCT07352566·10 enrolled

A Study of Baricitinib (LY3009104) in Participants With Moderate-to-Severe Atopic Dermatitis

Completed· Eli Lilly logo

Eli Lilly·Phase 2·NCT02576938·124 enrolled

Pediatric Atopic Dermatitis (AD) Internet Survey

Withdrawn·WWake Forest University·N/A·NCT01385527

Carpal Tunnel Syndrome2 trials

Dexmedetomidine Versus Triamcinolone Treatment of Carpal Tunnel Syndrome

Completed·—·N/A·NCT04961281·60 enrolled

Dexmedetomidine Versus Triamcinolone Treatment in Carpal Tunnel Syndrome

Unknown status·—·N/A·NCT05624866·60 enrolled

Dexamethasone2 trials

Long Term Effectiveness of Trigger Finger Injections With Triamcinolone vs. Dexamethasone

Completed·EEricka Lawler·Phase 4·NCT03641508·69 enrolled

A Comparison of Dexamethasone and Triamcinolone for Ultrasound-guided Occipital C2 Nerve Blocks

Withdrawn·NNorthwestern University·Phase 4·NCT02655523

Macular Edema2 trials

The Comparison Between the Therapeutic Affect of Intravitreal Diclophenac and Triamcinolone in Persistent Uveitic Cystoids Macular Edema

Unknown status·SShahid Beheshti University of Medical Sciences·Phase 1·NCT00893854

Efficacy and Tolerance Comparison Between Subconjunctival Injection of Triamcinolone and Intravitreal Implant of Dexamethasone for the Treatment of Inflammatory Macular Edema

Completed·NNantes University Hospital·Phase 3·NCT02556424·114 enrolled

Shoulder pain2 trials

Treatment of Subacromial Shoulder Pain by Individual or Group Physiotherapy Following Corticosteroid Injection

Completed·SSouth Eastern Health and Social Care Trust·N/A·NCT04058522·136 enrolled

Suprascapular Nerve Block for Treatment of Shoulder Pain in Individuals With Spinal Cord Injuries

Withdrawn·UUniversity of Miami·Phase 4·NCT05364099

Analgesia1 trial

Effect of Addition of Steroids on Duration of Analgesia

Active, not recruiting·UUniversity of California, Los Angeles·Phase 1·NCT04126824·28 enrolled

Lumbar Disc Herniation1 trial

"Platelet-Rich Plasma" Epidural Injection an Emerging Strategy in Lumbar Disc Herniation

Completed·QQueen Savang Vadhana Memorial Hospital, Thailand·N/A·NCT05234840·30 enrolled

Pain1 trial

Use of Intravitreal Triamcinolone and Retrobulbar Chlorpromazine as Alternatives to the Management of Painful Blind Eye

Completed·—·N/A·NCT01404364·36 enrolled

MCI1 trial

Subcutaneous Sodium Deoxycholate Injections With or Without Triamcinolone for Reduction of Submental Fat

Completed·GGoldman, Butterwick, Fitzpatrick and Groff·Phase 4·NCT03241563·20 enrolled

Prospective1 trial

A Prospective Study of EUS Guided Celiac Block

Completed·IIndiana University··NCT00583271·127 enrolled

Vitiligo1 trial

Assessing the Efficacy of Needling With or Without Corticosteroids in the Repigmentation of Vitiligo

Terminated·RRutgers, The State University of New Jersey·Phase 2/3·NCT02191748·22 enrolled

Thyroid1 trial

Local Triamcinolone Injection in Active Thyroid Orbitopathy

Unknown status·HHaEmek Medical Center, Israel·N/A·NCT01280214·30 enrolled

Treatment1 trial

Lidocaine and Triamcinolone vs Saline Trigger Point Injection for Treatment of Chronic Abdominal Wall Pain

Withdrawn·TTemple University·Phase 4·NCT02748395

Lateral Epicondylitis1 trial

Treatment Study of Steroid Injection and Physical Therapy for Acute Lateral Epicondylitis

Completed·UUniversity of Oslo·Phase 4·NCT00826462·177 enrolled

Retinal Vein Occlusion1 trial

Intravitreal Triamcinolone for Acute Branch Retinal Vein Occlusion

Completed·SShahid Beheshti University of Medical Sciences·Phase 2·NCT00370266·30 enrolled

Age-Related Macular Degeneration1 trial

A Study to Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

Completed· Johnson & Johnson logo

Johnson & Johnson·Phase 2·NCT05811351·305 enrolled

Pregnancy1 trial

Injection Treatment of Corticosteroid to Pelvic Ligament Insertions on Women With Longlasting Backpain After Pregnancy

Completed·SSundsvall Hospital·N/A·NCT00757016·38 enrolled

Uveitic Macular Edema1 trial

Study of Uveitic Macular Edema Treated With Ranibizumab or Steroids

Withdrawn·UUniversity of Utah·Phase 2·NCT00846625

ESS1 trial

IL-7 and IL-7R Expression in RA Patients With Active vs. Inactive Disease Treated With DMARD or CIMZIA

Completed·UUniversity of Illinois at Chicago·Phase 4·NCT02451748·32 enrolled

Total Knee Arthroplasty1 trial

Effects of Combined Topical and Systemic Steroid Administrations on Better Early Postoperative Pain Management in Total Knee Arthroplasty

Unknown status·TThe University of Hong Kong·Phase 4·NCT03901768·180 enrolled

Methylprednisolone1 trial

Triamcinolone Versus Methylprednisolone in Transversus Abdominis Plane Block

Completed·Gghada fouad·Phase 2/3·NCT04480775·84 enrolled

Nasal polyposis1 trial

Treatment of Early Nasal Polyposis With Topical Triamcinolone

Terminated·SSteward St. Elizabeth's Medical Center of Boston, Inc.·Phase 1/2·NCT01222871·1 enrolled

Actinic Keratosis1 trial

Eflornithine With or Without Triamcinolone in Preventing Nonmelanoma Skin Cancer in Patients With Actinic Keratosis

Completed·UUniversity of Arizona·Phase 2·NCT00021294

Chronic Pancreatitis1 trial

Efficacy of EUS-guided Celiac Plexus Blockade in Chronic Pancreatitis

Completed·TThe Cleveland Clinic·Phase 3·NCT00658736·40 enrolled

Sinus Surgery1 trial

Triamcinolone Packing Following Endoscopic Sinus Surgery

Completed·UUniversity of California, Los Angeles··NCT04841343·22 enrolled

TED1 trial

Medicated Punctured-Glove-Finger Spacer Study

Completed·SSt. Paul's Hospital, Canada·Phase 4·NCT01420471·50 enrolled

Botulinum Toxin1 trial

Botulinum Toxins Intralesional Injection for Scar Pain

Unknown status·KKaohsiung Medical University·Phase 4·NCT03982862·20 enrolled

Ultrasound1 trial

Ultrasound Guided Transversus Abdominis Plane (TAP) vs. Trigger Point Injection (TPI) for Abdominal Wall Pain

Completed·MMayo Clinic·Phase 2·NCT01906944·62 enrolled

Oral Lichen Planus1 trial

The Effect of Topical Curcumin Versus Topical Corticosteroid on Management of Oral Lichen Planus Patients

Unknown status·—·Phase 1·NCT03877679·40 enrolled

Total Knee Replacement1 trial

Outcomes of Injections in Patients Waiting for Total Knee Replacement

Unknown status·UUniversidade Federal Fluminense·Phase 4·NCT03090698·120 enrolled

Chronic Rhinosinusitis1 trial

Comparison of Two Steroid Nasal Implants Following Endoscopic Sinus Surgery for Chronic Rhinosinusitis

Withdrawn·WWeill Medical College of Cornell University·Phase 1·NCT03729310

Granulation Tissue1 trial

Silver Nitrate Application and Topical Corticosteroids for Hypergranulation Tissue

Unknown status·—·Phase 4·NCT02398539·50 enrolled

Psoriasis1 trial

Triamcinolone With Vitamin D Synergistic Efficacy in Psoriasis

Recruiting·WWright State University·Phase 1·NCT04036188·24 enrolled

Postoperative Pain Control1 trial

Postoperative Pain Control Following Vitreoretinal Surgery

Completed·EEmory University·Phase 4·NCT01995045·58 enrolled

Facial Pain1 trial

Ultrasound Guided Trigeminal Nerve Block for Typical or Atypical Facial Pain

Completed·NNorthwestern University·Phase 4·NCT02024724·60 enrolled

Shoulder Impingement Syndrome1 trial

Subacromial Injection With Corticosteroid Versus Nonsteroidal Anti-inflammatory Drugs (NSAID) in Shoulder Impingement Syndrome

Withdrawn·MMadigan Army Medical Center·N/A·NCT01449448

Allergic Rhinitis1 trial

An Efficacy and Safety Evaluation of Nasacort AQ in Children Ages 2-5 Years With Perennial Allergic Rhinitis

Completed· Sanofi logo

Sanofi·Phase 3·NCT00132925·460 enrolled

Cataract1 trial

The TRIBECA Study (TRIessence/Byqlovi for Easier CAtaract Surgery)

Not yet recruiting·RResearch Insight LLC·Phase 4·NCT07276802·40 enrolled

Radiofrequency Ablation1 trial

Sidekick vs Conventional Cannula in Lumbar Medial Branch Radiofrequency Ablation

Completed·SSaglik Bilimleri Universitesi Gulhane Tip Fakultesi·N/A·NCT07475689·82 enrolled

Local Anesthesia1 trial

Needle-Free Injection of Lidocaine for Local Anesthesia Prior to Trigger Digit Injection

Completed·—·N/A·NCT02084706·60 enrolled

Acne Vulgaris1 trial

Intralesional Injections of Triamcinolone for Acne Vulgaris

Completed·AACOM Labs·N/A·NCT06170593·20 enrolled

Bursitis1 trial

Relationship to Dose of Triamcinolone Acetonide and Methylyprednisolone to Improvement in Subacromial Bursitis

Completed·KKeesler Air Force Base Medical Center·N/A·NCT02242630·61 enrolled

Dysphagia1 trial

Effect of Local Steroid Application on a Cervical Plate Versus Intravenous Steroids on Dysphagia Following Anterior Cervical Discectomy and Fusion (ACDF)

Completed·NNorthwestern University·N/A·NCT02577991·80 enrolled

Oral Submucous Fibrosis1 trial

Comparison of Triamcinolone With Pentoxifylline and Vitamin- E Efficacy in the Treatment of Stage 2 and 3 Oral Submucous Fibrosis

Completed·—·Phase 4·NCT05660694·40 enrolled

Osteoarthritis, Knee1 trial

Evaluation of the Effect of Triamcinolone at Different Doses on Local Infiltration Anesthesia During Total Knee Arthroplasty

Completed·PPeking University Third Hospital·Approved·NCT05997238·120 enrolled

Hip Osteoarthritis1 trial

Randomized Trial on the Evaluation of the Effectiveness of One Single Bone Marrow Aspirate Hip Injection Versus Triamcinolone for Hip Osteoarthritis

Recruiting·TThe Cleveland Clinic·Phase 3·NCT04990128·100 enrolled

Cutaneous T-cell lymphoma1 trial

Valchlor Therapy in Conjunction With Triamcinolone 0.1% Ointment for the Treatment of Contact Dermatitis in Patients With Early Stage Cutaneous T-cell Lymphoma (Mechlorethamine Induced Dermatitis Avoidance Study)

Completed·RRochester Skin Lymphoma Medical Group, PLLC·Phase 2·NCT03380026·28 enrolled

Knee Osteoarthritis1 trial

Multi-Center, Randomized Controlled Trial Evaluating the Effect of Adipose Tissue Processed With the SyntrFuge™ System for Knee Osteoarthritis

Not yet recruiting·SSyntr Health Technologies, Inc.·Preclinical·NCT05526898·180 enrolled

Peripheral Nerve Stimulation1 trial

Peripheral Nerve Stimulation of Genicular Nerves Versus Conventional Therapy With Intra-articular Steroid Injection for Chronic Knee Pain: A Prospective, Randomized Pilot Study

Recruiting·MM.D. Anderson Cancer Center·Preclinical·NCT06004882·45 enrolled

Wound1 trial

A Comparative Study of Silver Nitrate, Triamcinolone, and Their Successive Combined Use on Hypergranulation Tissue in Traumatic Wounds: A Randomized Control Trial

Withdrawn·FFrancesco Egro·Preclinical·NCT06681194

Unspecified1 trial

Lung Health Study II

Completed·UUniversity of Minnesota·Phase 3·NCT00000569·1,116 enrolled

Regulatory

FDA Approval Timeline[5]

Jan 4, 1960

KENALOG-10

NDA NDA012041

Feb 1, 1965

KENALOG-40, KENALOG-80

NDA NDA014901

Sep 19, 1977

KENALOG-10

NDA NDA012041

Apr 7, 1978

KENALOG-40, KENALOG-80

NDA NDA014901

Apr 7, 1978

KENALOG-40, KENALOG-80

NDA NDA014901

Dec 28, 1978

KENALOG-10

NDA NDA012041

Jul 17, 1979

KENALOG-10

NDA NDA012041

Jul 17, 1979

KENALOG-40, KENALOG-80

NDA NDA014901

Jul 27, 1979

KENALOG-40, KENALOG-80

NDA NDA014901

Aug 21, 1979

KENALOG-40, KENALOG-80

NDA NDA014901

Aug 21, 1979

KENALOG-10

NDA NDA012041

May 20, 1980

KENALOG-40, KENALOG-80

NDA NDA014901

May 20, 1980

KENALOG-10

NDA NDA012041

Apr 1, 1981

KENALOG-10

NDA NDA012041

Jan 1, 1982

ARISTOCORT

NDA NDA011161

Jan 1, 1982

KENACORT

NDA NDA011283

Jan 12, 1982

KENALOG-10

NDA NDA012041

Jun 30, 1982

KENALOG-40, KENALOG-80

NDA NDA014901

Apr 13, 1984

KENALOG-40, KENALOG-80

NDA NDA014901

Jun 14, 1985

KENALOG-40, KENALOG-80

NDA NDA014901

Dec 3, 1985

KENALOG-10

NDA NDA012041

Dec 4, 1985

KENALOG-40, KENALOG-80

NDA NDA014901

Nov 19, 1986

KENALOG-10

NDA NDA012041

Nov 19, 1986

KENALOG-40, KENALOG-80

NDA NDA014901

Nov 30, 1987

KENALOG-10

NDA NDA012041

Nov 30, 1987

KENALOG-40, KENALOG-80

NDA NDA014901

Jul 19, 1991

KENALOG-10

NDA NDA012041

Jul 19, 1991

KENALOG-40, KENALOG-80

NDA NDA014901

Sep 25, 1991

KENALOG-10

NDA NDA012041

Feb 14, 1992

KENALOG-40, KENALOG-80

NDA NDA014901

Aug 30, 1993

KENALOG-10

NDA NDA012041

Aug 30, 1993

KENALOG-10

NDA NDA012041

Oct 6, 1993

KENALOG-10

NDA NDA012041

Mar 28, 1994

KENALOG-40, KENALOG-80

NDA NDA014901

Jan 10, 1995

KENALOG-10

NDA NDA012041

Jan 10, 1995

KENALOG-40, KENALOG-80

NDA NDA014901

May 22, 1996

KENALOG-10

NDA NDA012041

May 22, 1996

KENALOG-40, KENALOG-80

NDA NDA014901

Feb 3, 1998

KENALOG-10

NDA NDA012041

Jan 5, 2001

KENALOG-40, KENALOG-80

NDA NDA014901

Jun 15, 2001

KENALOG-10

NDA NDA012041

Nov 20, 2006

KENALOG-10

NDA NDA012041

Nov 20, 2006

KENALOG-40, KENALOG-80

NDA NDA014901

Jan 28, 2010

KENALOG-10

NDA NDA012041

Jan 28, 2010

KENALOG-40, KENALOG-80

NDA NDA014901

Jun 16, 2011

KENALOG-10

NDA NDA012041

Jun 16, 2011

KENALOG-40, KENALOG-80

NDA NDA014901

Jul 15, 2011

KENALOG-40, KENALOG-80

NDA NDA014901

Jul 15, 2011

KENALOG-10

NDA NDA012041

Jul 3, 2014

KENALOG-10

NDA NDA012041

Jul 3, 2014

KENALOG-40, KENALOG-80

NDA NDA014901

Oct 26, 2015

KENALOG-10

NDA NDA012041

Oct 26, 2015

KENALOG-40, KENALOG-80

NDA NDA014901

Mar 29, 2018

KENALOG-40, KENALOG-80

NDA NDA014901

Mar 29, 2018

KENALOG-10

NDA NDA012041

Jun 22, 2018

KENALOG-40, KENALOG-80

NDA NDA014901

Jun 22, 2018

KENALOG-10

NDA NDA012041

Apr 12, 2019

KENALOG-40, KENALOG-80

NDA NDA014901

Jun 5, 2024

KENALOG-10

NDA NDA012041

Jun 5, 2024

KENALOG-40, KENALOG-80

NDA NDA014901

Aug 9, 2024

KENALOG-40, KENALOG-80

NDA NDA014901

Aug 14, 2024

KENALOG-10

NDA NDA012041

Sources

References

[1]
ClinicalTrials.gov — 80 trial records for Triamcinolone. U.S. National Library of Medicine, National Institutes of Health.
[2]
MedlinePlus Drug Information — Kenalog drug information. U.S. National Library of Medicine, National Institutes of Health.
[3]
ChEMBL — Triamcinolone compound record. European Bioinformatics Institute (EMBL-EBI).
[4]
Open Targets Platform — Drug–disease associations for Triamcinolone. EMBL-EBI & Wellcome Sanger Institute.
[5]
OpenFDA — FDA approval records (NDA NDA012041). U.S. Food & Drug Administration.
[6]
SEC EDGAR — Bassett Healthcare company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Mechanism of Action: Glucocorticoid Receptor Agonist[3]
Modality: Small molecule[3]
Highest Phase: Approved[1]
Company: BBassett Healthcare

Kenalog

Status by Indication[4][1]

Competitive Landscape

Expected Milestones

Q4 2026

Q1 2027

Q3 2027

Q4 2027

Trials by Indication[1]

Steroid4 trials

Osteoarthritis4 trials

Diabetic Macular Edema4 trials

Keloid4 trials

Steroid Injection4 trials

Arthritis3 trials

Atopic Dermatitis3 trials

Carpal Tunnel Syndrome2 trials

Dexamethasone2 trials

Macular Edema2 trials

Shoulder pain2 trials

Analgesia1 trial

Lumbar Disc Herniation1 trial

Pain1 trial

MCI1 trial

Prospective1 trial

Vitiligo1 trial

Thyroid1 trial

Treatment1 trial

Lateral Epicondylitis1 trial

Retinal Vein Occlusion1 trial

Age-Related Macular Degeneration1 trial

Pregnancy1 trial

Uveitic Macular Edema1 trial

ESS1 trial

Total Knee Arthroplasty1 trial

Methylprednisolone1 trial

Nasal polyposis1 trial

Actinic Keratosis1 trial

Chronic Pancreatitis1 trial

Sinus Surgery1 trial

TED1 trial

Botulinum Toxin1 trial

Ultrasound1 trial

Oral Lichen Planus1 trial

Total Knee Replacement1 trial

Chronic Rhinosinusitis1 trial

Granulation Tissue1 trial

Psoriasis1 trial

Postoperative Pain Control1 trial

Facial Pain1 trial

Shoulder Impingement Syndrome1 trial

Allergic Rhinitis1 trial

Cataract1 trial

Radiofrequency Ablation1 trial

Local Anesthesia1 trial

Acne Vulgaris1 trial

Bursitis1 trial

Dysphagia1 trial

Oral Submucous Fibrosis1 trial

Osteoarthritis, Knee1 trial

Hip Osteoarthritis1 trial

Cutaneous T-cell lymphoma1 trial

Knee Osteoarthritis1 trial

Peripheral Nerve Stimulation1 trial

Wound1 trial

Unspecified1 trial

FDA Approval Timeline[5]

References

Drug Info

Quick Facts

Related News